GlassScriptPhysician profile
Amy E Clifton
NPI 1932351582
$3,248.24
in general payments reported to CMS, 2019-2025
29 companies · $578 in 2025
The $578 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.06 · 2022: $345 · 2023: $1,155 · 2024: $1,091 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,824.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.75 | 2022-2024 | Jardiance |
| Pfizer INC. | $328.37 | 2021-2025 | |
| Novo Nordisk INC | $324.49 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $248.85 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $226.90 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $215.22 | 2023-2025 | Verquvo |
| Amgen INC. | $213.87 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $199.72 | 2023-2025 | Farxiga |
| Philips North America LLC | $145.16 | 2022-2025 | Ecc Solutions, (Ck7) Extended Holter, (Ck4) Mcot |
| Irhythm Technologies, INC. | $134.63 | 2023-2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| E.R. Squibb & Sons, L.L.C. | $133.77 | 2022-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $124.83 | 2023 | Watchman Access System, Watchman |
| Lexicon Pharmaceuticals, INC. | $78.55 | 2023-2024 | Inpefa |
| Pharmacyclics LLC, An Abbvie Company | $75.91 | 2022-2023 | Imbruvica, Epkinly |
| Glaxosmithkline, LLC. | $66.43 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $61.64 | 2022-2024 | |
| Baxter Healthcare | $53.01 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $45.74 | 2024-2025 | Fruzaqla |
| Edwards Lifesciences Corporation | $41.96 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals International, Plc | $36.49 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $25.88 | 2025 | Assure Wcd |
| Abiomed | $25.50 | 2023 | Impella |
| Biofrontera INC. | $19.21 | 2022 | |
| Medtronic, INC. | $15.62 | 2022 | |
| Atricure, INC. | $15.47 | 2023 | |
| Esperion Therapeutics, INC. | $15.18 | 2023 | Nexletol |
| Iovance Biotherapeutics, INC. | $14.52 | 2025 | Amtagvi |
| Janssen Biotech, INC. | $13.69 | 2022 | |
| Genzyme Corporation | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Clifton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.